PEOPLE - Xtent makes appointment:
This article was originally published in Clinica
Executive Summary
Drug-eluting stent developer Xtent (Menlo Park, California) has appointed Michael Eagle to its board of directors. Mr Eagle, who has over 30 years experience in the life-sciences industry, was most recently vice-president of manufacturing at Eli Lilly, a post he held for eight years. He is on the board of several companies, including: Favrille (biopharma, chairman); Radiant Medical (endovascular therapeutic cooling); Siegel-Robert (industrial manufacturing); Somaxon Pharmaceutical; and Micrus Endovascular (cerebrovascular implants and disposables).